Investing-News.Com
Information for Investors

HOLLIS-EDEN PHARM, (HEPH) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

HOLLIS-EDEN PHARM, (HEPH) Stock Rating Learn More

Our Overall Rating on Hollis-Eden Pharmaceuticals Inc,  HEPH is BUY
StockPickReport.Com research suggests HEPH's price will move higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

With StockPickReport.Com's "Buy" rating, stochastic and "relative strength" numbers may agree, but not in all cases.

Investors, traders, and other market participants may find this a good opportunity to buy HEPH, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains (although those gains may not be as signficant as gains experienced in conjunction with a "Strong Buy" rating).

Trading volume seems to be going up and HEPH's closing price moved up during the week before this rating was initiated.

Our BUY Rating on HEPH was issued on 03/25/08

HOLLIS-EDEN PHARM Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces HOLLIS-EDEN PHARM Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in HOLLIS-EDEN PHARM buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on HOLLIS-EDEN PHARM. This software is specially designed to give precision entry and exit points on HOLLIS-EDEN PHARM, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When HOLLIS-EDEN PHARM Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even HOLLIS-EDEN PHARM, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: bp stock quote 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript (Business Wire)

HOLLIS EDEN PHARMACEUTICALS INC /DE/ Financials (EDGAR Online Financials)

New Star Analyst Rankings for HOLLIS-EDEN PHARM (StarMine)

Hollis-Eden Pharmaceuticals Updates Upcoming Investor Conference Presentations and Webcasts (Business Wire)

Hollis-Eden Pharmaceuticals Earnings Call scheduled for 2:00 pm ET today (CCBN)

HOLLIS EDEN PHARMACEUTICALS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Sta (EDGAR Online)

Q3 2008 Hollis-Eden Pharmaceuticals Earnings Release - Before Market Open (CCBN)

Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Programs; Announces Third Quarter 2008 Financial Results (Business Wire)

HOLLIS EDEN PHARMACEUTICALS INC /DE/ Files SEC form 10-Q, Quarterly Report (EDGAR Online)

Hollis-Eden Pharmaceuticals to Webcast Investor Conference Presentations and Third Quarter 2008 Conference Call (Business Wire)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.